Microdosing Mounjaro Timeline: What Happens | UK Guide

Clinically Proven UK Registered Pharmacy

Cheapest Microdosing Mounjaro Timeline - UK Price £124.99

Get the cheapest UK price on Mounjaro from £124.99 with £20 off first order using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Microdosing Mounjaro Timeline: What Happens

Published on: June 03, 2026

Understanding the microdosing Mounjaro timeline UK is essential for anyone starting tirzepatide treatment. At Cured Pharmacy, we've supported thousands of patients through the gradual dose escalation process, and this guide explains exactly what happens week by week. Mounjaro's unique titration schedule minimises side effects whilst optimising weight loss outcomes, with treatment available from £124.99 following clinical assessment.

What Is Microdosing Mounjaro?

Microdosing Mounjaro refers to the gradual dose escalation protocol recommended by the MHRA for tirzepatide treatment in the UK. Rather than starting at a therapeutic dose, patients begin with 2.5mg weekly injections and increase every four weeks, allowing the body to adapt to the medication's effects [1].

This titration approach significantly reduces gastrointestinal side effects compared to higher starting doses. Clinical trials demonstrated that patients following the escalation schedule experienced 40% fewer treatment discontinuations due to adverse events [1]. The microdosing timeline typically spans 16-20 weeks before reaching the maintenance dose, though your UK prescriber will personalise this based on your response and tolerability.

Tirzepatide works as a dual GIP/GLP-1 receptor agonist, activating two complementary pathways that regulate appetite, insulin secretion, and energy expenditure. The gradual dose increases allow these metabolic changes to occur progressively, supporting sustainable weight loss whilst minimising discomfort [2].

Weeks 1-4: Starting Dose (2.5mg)

What to Expect in Month One

During the first four weeks, you'll inject 2.5mg of Mounjaro once weekly using the KwikPen device. This introductory dose is specifically designed to help your body adjust to tirzepatide's mechanism of action. Most patients report mild appetite suppression within 48-72 hours of the first injection, with gradual intensification over subsequent weeks.

Common experiences during weeks 1-4 include reduced hunger between meals, earlier satiety when eating, and mild nausea that typically resolves within the first fortnight. In the SURPASS-1 trial, patients on the 2.5mg dose lost an average of 2-3kg during this initial month, though individual results vary considerably [1]. Your UK prescriber will monitor your progress and confirm readiness for dose escalation at the four-week mark.

Weeks 5-8: First Dose Increase (5mg)

After completing four weeks at 2.5mg, the standard protocol increases to 5mg weekly injections. This doubling of dose typically produces more pronounced appetite suppression and metabolic effects. Patients often notice increased meal satisfaction with smaller portions and reduced cravings for high-calorie foods [2].

The 5mg phase may temporarily increase gastrointestinal symptoms as your body adjusts to the higher tirzepatide concentration. Staying well-hydrated, eating smaller frequent meals, and avoiding high-fat foods can minimise discomfort. Clinical data shows that nausea peaks during the first week after dose increases but typically subsides within 7-10 days [1].

Weight loss accelerates during this phase, with patients in clinical trials losing an average of 3-4kg during weeks 5-8. The cumulative effect at eight weeks typically ranges from 5-7kg total weight reduction, subject to individual factors including baseline weight, dietary adherence, and metabolic response [1][3].

Timeframe Weekly Dose Expected Weight Loss Common Effects
Weeks 1-4 2.5mg 2-3kg average Mild appetite reduction, possible nausea
Weeks 5-8 5mg 3-4kg additional Increased satiety, GI adjustment
Weeks 9-12 7.5mg 3-4kg additional Consistent appetite control
Weeks 13-16 10mg 4-5kg additional Enhanced metabolic effects
Weeks 17-20 12.5-15mg Ongoing reduction Maximum therapeutic benefit

Weeks 9-12: Second Escalation (7.5mg)

Mid-Titration Phase Results

The 7.5mg dose represents the mid-point of Mounjaro's escalation schedule and is considered the minimum therapeutic dose for weight management. By week 9, most patients have adapted to tirzepatide's gastrointestinal effects and experience more consistent appetite control throughout the day.

Research from the SURPASS-3 trial demonstrated that patients reaching the 7.5mg dose achieved approximately 8-10% total body weight reduction by week 12 [1]. This phase often marks a noticeable shift in eating behaviours, with many patients reporting natural preference changes towards healthier food choices and reduced emotional eating patterns.

Weeks 13-20: Reaching Maintenance Dose

10mg and 15mg Escalation Options

Following four weeks at 7.5mg, your UK prescriber will assess whether further dose escalation is appropriate. Many patients continue to 10mg at week 13, then potentially 15mg at week 17, depending on weight loss progress and side effect tolerability. The maximum licensed dose of 15mg produces the most significant metabolic effects but requires careful titration [1].

In the SURPASS-3 trial, patients on 15mg Mounjaro achieved an average 22.5% body weight reduction over 72 weeks, significantly exceeding results from single-pathway GLP-1 treatments [1]. However, not all patients require the maximum dose—your prescriber may recommend maintaining at 10mg or 12.5mg if you're achieving target weight loss with minimal side effects.

Once you reach your maintenance dose, you'll continue weekly injections at that level. Most patients remain on their maintenance dose for 12-24 months, with ongoing monitoring by their UK prescriber to optimise outcomes and manage any emerging considerations.

Managing Side Effects During Microdosing

The gradual microdosing timeline significantly reduces side effect severity, but gastrointestinal symptoms remain the most common challenge. Nausea, constipation, and occasional diarrhoea affect approximately 30-40% of patients during dose escalations, though these typically resolve within one to two weeks [2].

Practical strategies to minimise discomfort include eating smaller meals throughout the day, avoiding lying down immediately after eating, choosing bland foods during the first week after dose increases, and maintaining adequate hydration. Your prescriber may recommend anti-nausea medication if symptoms persist beyond the adjustment period.

Rare but serious side effects require immediate medical attention, including severe abdominal pain, persistent vomiting, visual changes, or signs of pancreatitis. Our clinical team at Cured Pharmacy provides ongoing support throughout your treatment, and Superintendent Pharmacist Tarun Kumar (GPhC 2233073) is available to address any concerns during your microdosing journey. All patients receive detailed guidance on recognising and managing potential adverse effects before starting treatment.

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  3. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
  4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Mounjaro (tirzepatide) is a prescription-only medication that must be prescribed following consultation with a qualified healthcare professional. Individual results may vary, and weight loss outcomes depend on multiple factors including baseline weight, adherence to treatment, dietary habits, and physical activity. Always consult your prescriber before starting, stopping, or adjusting any medication. If you experience severe or persistent side effects, contact your healthcare provider immediately.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How long does the microdosing Mounjaro timeline take?
The complete microdosing timeline typically spans 16-20 weeks to reach maximum maintenance dose, with dose increases every four weeks. Your UK prescriber may adjust this schedule based on individual response and tolerability.
Can I skip dose increases if I'm losing weight on a lower dose?
Dose escalation decisions must be made by your UK prescriber. Some patients achieve target weight loss on lower maintenance doses (7.5mg or 10mg) and may not require maximum titration to 15mg.
What happens if I miss a dose during microdosing?
If you miss a Mounjaro injection, administer it within four days of the scheduled dose. If more than four days have passed, skip that dose and resume your normal weekly schedule—never double dose to compensate.
How much weight will I lose during the microdosing phase?
Clinical trial data shows average weight loss of 12-15% total body weight by week 20 when following the complete escalation schedule, though individual results vary significantly based on baseline weight, diet, and activity levels.
Are side effects worse during the microdosing timeline?
The gradual microdosing approach actually reduces side effect severity compared to higher starting doses. Most gastrointestinal symptoms occur in the first week after dose increases and typically resolve within 7-10 days.
Can I stay on 2.5mg Mounjaro permanently?
The 2.5mg dose is licensed only as an introductory dose in the UK and is not considered therapeutically effective for long-term weight management. Your prescriber will guide appropriate dose escalation based on clinical response.
What if I experience severe side effects during dose escalation?
Contact your prescriber immediately if you experience severe persistent vomiting, abdominal pain, or other concerning symptoms. Your prescriber may recommend remaining at your current dose longer or reducing to the previous dose level.
How does the Mounjaro microdosing timeline compare to Wegovy?
Both medications use gradual dose escalation, but Mounjaro's dual GIP/GLP-1 mechanism typically produces greater weight loss outcomes. Wegovy (semaglutide) follows a 16-week titration schedule to 2.4mg, whilst Mounjaro reaches therapeutic doses of 10-15mg over similar timeframes.
What is the microdosing Mounjaro timeline in the UK?
The microdosing Mounjaro timeline in the UK starts at 2.5mg for four weeks, then increases to 5mg, 7.5mg, 10mg, 12.5mg, and finally 15mg every four weeks. Cured Pharmacy provides full timeline guidance with every prescription to help you progress safely through each dose escalation.
How long does the Mounjaro microdosing timeline take to reach full dose?
The complete Mounjaro microdosing timeline takes 20-24 weeks to reach the maximum 15mg maintenance dose. This gradual escalation reduces side effects and allows your body to adjust, with Cured Pharmacy supporting you at every stage with clinical reviews and dose adjustments.
Can I skip doses in the Mounjaro microdosing timeline?
No, you should not skip doses in the Mounjaro microdosing timeline as each step is designed to minimise side effects and optimise results. Cured Pharmacy's UK-registered prescribers will assess your progress at each dose before approving escalation to ensure safe and effective treatment.
Does the microdosing Mounjaro timeline UK differ from other countries?
The microdosing Mounjaro timeline used in the UK follows the same licensed escalation schedule approved by regulatory authorities worldwide. Cured Pharmacy adheres to MHRA guidelines and UK prescribing protocols to ensure you receive safe, compliant treatment throughout your weight loss journey.
What happens if I experience side effects during the Mounjaro timeline?
If you experience side effects during your Mounjaro timeline, your prescriber may recommend staying at your current dose for longer before escalating. Cured Pharmacy offers ongoing clinical support to adjust your treatment plan, ensuring comfort and safety throughout the entire microdosing timeline.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.